The Food and Drug Administration on Tuesday will issue draft guidance for how companies developing cell and gene therapies ...
Silver Spring, MD, June 02, 2026 (GLOBE NEWSWIRE) -- The U.S. Food and Drug Administration (FDA) today issued draft guidance ...
The US Food and Drug Administration (FDA) has proposed guidance to reduce the need for animal testing in the development of ...
The US Food and Drug Administration has updated its draft guidance on how the drug and medical device makers should communicate with payors and other stakeholders about their products. The updates are ...
FDA’s draft guidance allows sponsors to leverage public and platform knowledge for CMC, nonclinical, and clinical support of ...
FDA revises 2022 human factors guidance with new risk-based categories, device modification examples, and 60-day ...
Opinion: In response to the FDA's updated cybersecurity guidance on medical devices, manufacturers should follow "secure by design" principles, ensure cyber transparency, conduct threat modeling, and ...
Sponsors are expected to justify relevance and applicability when relying on prior CMC, nonclinical, or clinical information to increase review efficiency. Platform knowledge can derive from internal ...
Mario covers technology in health care, including FDA regulation of artificial intelligence; how Medicare pays for health tech; the use of AI in clinical care; mental health chatbots; and consumer ...
The FDA's new guidelines permit unauthorized e-cigarettes and nicotine pouches in the U.S., raising concerns among agency ...
The FDA’s press release noted that the guidance supports development of an array of cell and gene therapy products, including ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results